Voyager Therapeutics (VYGR) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order by the Chairman, with the CEO presiding and directors, nominees, auditors, and counsel present virtually.

• Meeting conducted in accordance with bylaws and Delaware law, with agenda and proxy materials distributed to shareholders of record.

• Rules of conduct outlined, quorum confirmed, and meeting recorded.

Board and executive committee updates

• Nomination of three Class II directors to serve until the 2029 annual meeting and until successors are elected.

Shareholder proposals

• Four proposals presented: election of directors, advisory vote on executive compensation, ratification of auditors, and amendment to increase authorized shares.

• Board will consider the outcome of the advisory vote on executive compensation for future policy decisions.